Q&A

Secrets To Successful Development For Emerging Biotechs

GettyImages-1413600685-lab-team-collaboration-computer-research

Emerging biotechs continue to take the industry by storm with rapid therapeutic innovations. In their quest to find an experienced and capable CDMO partner, they are looking for teams that can accommodate their distinct goals and funding challenges. In a recent webinar hosted by Singota Solutions, Singota’s Senior Director of Business Development and Manufacturing, William Powers, spoke to the challenges that many early-phase biotechs find themselves up against, including access to limited quantities of API and minimal regulatory experience, and how a CDMO can best support them.

In an interactive Q&A session with webinar attendees, Powers spoke to the flexible approaches a CDMO can leverage to accommodate early-phase clients and highlighted Singota’s strategies for upholding rapid timelines. Ready to learn more? Download the full article to read Powers' insightful responses to attendee questions.

access the Q&A!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.

Subscribe to Outsourced Pharma X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Outsourced Pharma